Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more
This newsletter includes
- A policy brief discussing how psychedelic therapy could hold promise for the treatment of neurodegenerative diseases like Alzheimer’s
- A roundup of several states introducing psychedelic bills
- A Republican leader is optimistic about Trump nominee RFK Jr. on psychedelics
- Colorado opens for business
- Commentaries on clinical trial designs for psychedelics and DMT research quotas
Policy brief on psychedelics and neurodegenerative treatments
Reason Foundation has published a policy brief on the use of psychedelics to treat neurodegenerative diseases. Research shows psychedelic substances decrease brain inflammation and increase neuroplasticity, which can allay the onset of these diseases.
Former Texas Gov. Rick Perry praises Trump HHS pick Robert F. Kennedy Jr.
Former Texas Gov. Rick Perry says that President Donald Trump’s nominee to lead the U.S. Department of Health and Human Services, Robert F. Kennedy Jr., is a “gift” for psychedelics reform. Perry appeared on the Joe Rogan podcast with Bryan Hubbard, who advocates for the use of the psychedelic substance ibogaine to treat mental illness and opioid addiction.
States introduce psychedelics bills
A slew of bills have been introduced into state legislatures, from New York to Missouri, aiming to improve access to psychedelics. Multiple competing bills have been introduced in some states, such as Massachusetts. Read more details in Reason Foundation’s state roundup.
Colorado opens license application window
Colorado has begun accepting applications for the first set of licenses within its regulated psychedelic market. Ballot Proposition 122, passed in 2022, tasked state agencies with creating licenses for training schools, service centers, and manufacturers of psilocybin. A commercial market for regulated psilocybin services should become operational later this year.
Psychedelics need alternatives to ‘double-blind’ clinical trials
Reason Foundation analyst Madison Carlino offers commentary on why clinical trials with psychedelics should be able to use alternatives to “double-blind” placebo-controlled methods.
DEA increases 2025 DMT production quotas
In this commentary, Reason Foundation analyst Madison Carlino praises the Drug Enforcement Agency’s increased 2025 production quota for DMT so that more research can be performed with the substance.
The post Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more appeared first on Reason Foundation.
Source: https://reason.org/psychedelics-policy/psychedelics-policy-newsletter-states-propose-legalization-optimism-for-trump-administration-nominees-and-more/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Online: | |
| Visits: | 1,676,077,685 |
| Stories: | 8,349,763 |
Whistler Blowers, Insiders
